Cargando…

Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment

BACKGROUND: The REDUCE-RISK trial was set up to compare the effectiveness of weekly subcutaneously administered methotrexate with daily oral azathioprine or 6-mercaptopurine in low-risk Crohn disease (CD) or subcutaneously administered adalimumab (ADA) in high-risk CD in a pediatric population (age...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neyt, Mattias, Christiaens, Annick, Aloi, Marina, de Ridder, Lissy, Croft, Nicholas M, Koletzko, Sibylle, Levine, Arie, Turner, Dan, Russell, Richard K, Ruemmele, Frank M, Veereman, Gigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870354/ https://www.ncbi.nlm.nih.gov/pubmed/33492239 http://dx.doi.org/10.2196/13888

Ejemplares similares

Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn’s disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course
por: Harris, Rachel E, et al.
Publicado: (2020)

International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study
por: Aardoom, Martine A, et al.
Publicado: (2020)

A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease
por: Aardoom, Martine A., et al.
Publicado: (2019)

The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World
por: Church, Peter C., et al.
Publicado: (2018)

The Incidence and Characteristics of Venous Thromboembolisms in Paediatric-Onset Inflammatory Bowel Disease: A Prospective International Cohort Study Based on the PIBD-SETQuality Safety Registry
por: Aardoom, Martine A, et al.
Publicado: (2021)

The cost-utility of catheter ablation of atrial fibrillation: a systematic review and critical appraisal of economic evaluations
por: Neyt, Mattias, et al.
Publicado: (2013)

Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real‐world patient mix
por: Atia, Ohad, et al.
Publicado: (2022)

Exenatide extended-release; clinical trials, patient preference, and economic considerations
por: Doggrell, Sheila A
Publicado: (2013)

Safety of percutaneous aortic valve insertion. A systematic review
por: Van Brabandt, Hans, et al.
Publicado: (2009)

Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents
por: Croft, Nicholas M, et al.
Publicado: (2022)

Long-Term Safety and Efficacy of Prebiotic Enriched Infant Formula—A Randomized Controlled Trial
por: Neumer, Franka, et al.
Publicado: (2021)

Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
por: Neyt, Mattias, et al.
Publicado: (2014)

TEST (Trial of Eczema allergy Screening Tests): protocol for feasibility randomised controlled trial of allergy tests in children with eczema, including economic scoping and nested qualitative study
por: Ridd, Matthew J, et al.
Publicado: (2019)

Statistical power considerations in genotype-based recall randomized controlled trials
por: Atabaki-Pasdar, Naeimeh, et al.
Publicado: (2016)

Methodological considerations for a randomised controlled trial of podiatry care in rheumatoid arthritis: lessons from an exploratory trial
por: Turner, Deborah E, et al.
Publicado: (2007)

Does tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysis
por: Van den Bruel, Ann, et al.
Publicado: (2010)

First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysis
por: Neyt, Mattias, et al.
Publicado: (2018)

Considerations for Embedding Inclusive Research Principles in the Design and Execution of Clinical Trials
por: Peters, Ubong, et al.
Publicado: (2022)

Extending Vulnerability Assessment to Include Life Stages Considerations
por: Hodgson, Emma E., et al.
Publicado: (2016)

Human Anatomy, Including Structure and Development and Practical Considerations
Publicado: (1907)

Latin American Considerations for Infant and Young Child Formulae
por: Ladino, Liliana, et al.
Publicado: (2021)

Economic considerations in the management of Alzheimer’s disease
por: Zhu, Carolyn W, et al.
Publicado: (2006)

Design Considerations for Clinical Trials in Aphasia
por: Palmer, Rebecca
Publicado: (2020)

Clinical Trial Considerations in Neuro-oncology
por: Lee, Eudocia Q.
Publicado: (2021)

Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions
por: Neyt, Mattias, et al.
Publicado: (2010)

Metabolic changes during exclusive enteral nutrition in pediatric Crohn’s disease patients
por: Marques, Jair G., et al.
Publicado: (2022)

An economic evaluation of an online computer-tailored smoking cessation intervention that includes message frame-tailoring: A randomized controlled trial
por: Altendorf, Maria B., et al.
Publicado: (2022)

Should EOAD patients be included in clinical trials?
por: Szigeti, Kinga, et al.
Publicado: (2011)

Economic evaluation alongside pragmatic randomised trials: developing a standard operating procedure for clinical trials units
por: Edwards, Rhiannon T, et al.
Publicado: (2008)

Piersol's Human Anatomy: Including Structure and Development and Practical Considerations
Publicado: (1931)

Congenital High-Scapula, with Which Is Included a Consideration of Brevicollis
por: Greig, David M.
Publicado: (1924)

Economic considerations for bariatric surgery and morbid obesity
por: Frezza, Eldo E, et al.
Publicado: (2009)

Economic considerations in the treatment of systemic allergic reactions
por: Westermann-Clark, Emma, et al.
Publicado: (2018)

Economic evaluation of meningococcal vaccines: considerations for the future
por: Christensen, Hannah, et al.
Publicado: (2019)

Practical considerations for adaptive trial design and implementation
por: He, Weili, et al.
Publicado: (2014)

Statistical considerations for dominant lethal mutagenic trials.
por: Salsburg, D S
Publicado: (1973)

Consideration of Ayurvedic diagnostics in design of clinical trials
por: Manohar, P. Ram
Publicado: (2013)

Basic Design Considerations for Clinical Trials in Oncology
por: Piantadosi, Steven, et al.
Publicado: (1992)

Clinical trials waiver in India-some considerations
por: Juneja, Atul, et al.
Publicado: (2018)

Design and Conduct Considerations for First‐in‐Human Trials
por: Shen, Jie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_98po4n794rvebgp2hgcogopp7c